These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 9606180
1. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. Kropshofer H, Vogt AB, Thery C, Armandola EA, Li BC, Moldenhauer G, Amigorena S, Hämmerling GJ. EMBO J; 1998 Jun 01; 17(11):2971-81. PubMed ID: 9606180 [Abstract] [Full Text] [Related]
3. Quality control of MHC class II associated peptides by HLA-DM/H2-M. Vogt AB, Arndt SO, Hämmerling GJ, Kropshofer H. Semin Immunol; 1999 Dec 01; 11(6):391-403. PubMed ID: 10625593 [Abstract] [Full Text] [Related]
4. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes. Schafer PH, Green JM, Malapati S, Gu L, Pierce SK. J Immunol; 1996 Dec 15; 157(12):5487-95. PubMed ID: 8955198 [Abstract] [Full Text] [Related]
5. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line. Ramachandra L, Kovats S, Eastman S, Rudensky AY. J Immunol; 1996 Mar 15; 156(6):2196 - 2204. PubMed ID: 8690909 [Abstract] [Full Text] [Related]
11. Enhanced interaction of HLA-DM with HLA-DR in enlarged vacuoles of hereditary and infectious lysosomal diseases. Lem L, Riethof DA, Scidmore-Carlson M, Griffiths GM, Hackstadt T, Brodsky FM. J Immunol; 1999 Jan 01; 162(1):523-32. PubMed ID: 9886429 [Abstract] [Full Text] [Related]
12. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. Hammond C, Denzin LK, Pan M, Griffith JM, Geuze HJ, Cresswell P. J Immunol; 1998 Oct 01; 161(7):3282-91. PubMed ID: 9759843 [Abstract] [Full Text] [Related]
15. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM. Peterson M, Sant AJ. J Immunol; 1998 Sep 15; 161(6):2961-7. PubMed ID: 9743359 [Abstract] [Full Text] [Related]
16. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing. Bellemare-Pelletier A, Tremblay J, Beaulieu S, Boulassel MR, Routy JP, Massie B, Lapointe R, Thibodeau J. J Leukoc Biol; 2005 Jul 15; 78(1):95-105. PubMed ID: 15817706 [Abstract] [Full Text] [Related]
19. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells. Stang E, Guerra CB, Amaya M, Paterson Y, Bakke O, Mellins ED. J Immunol; 1998 May 15; 160(10):4696-707. PubMed ID: 9590215 [Abstract] [Full Text] [Related]
20. DM and DO shape the repertoire of peptide-MHC-class-II complexes. Karlsson L. Curr Opin Immunol; 2005 Feb 15; 17(1):65-70. PubMed ID: 15653313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]